Submitted by Anonymous (not verified) on 21 August 2026 - 13:29
Orphan designation: milademetan tosilate monohydrate Treatment of soft tissue sarcoma, 20/03/2017 Withdrawn
Source:
Orphan designation: milademetan tosilate monohydrate Treatment of soft tissue sarcoma, 20/03/2017 Withdrawn